logo

For the Inventor, By the Inventor

Eugene, OR, United States of America

Lloyd Jay Dolby

This inventor holds 23 USPTO granted patents and 1 published patent application, primarily in Pharmaceutical Chemistry. Top assignees: Allergan, Inc., Euro-Celtique S.a., State Board of Higher Education for and on Behalf of the University of. Active years: 1981-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lloyd Jay Dolby. Retrieved from https://idiyas.com/inventor/lloyd-jay-dolby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 95.7

Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 108(Granted Patents)


Company Filing History:

goldMedal13 out of 2,287 
 
Allergan, Inc.
 patents
silverMedal9 out of 270 
 
Euro-Celtique S.a.
 patents
bronzeMedal1 out of 3 
 
State Board of Higher Education for and on Behalf of the University of
 patents

Years Active: 1981-2017

Loading Chart...
Areas of Expertise:
Benzimidazole Derivatives
Phosphodiesterase Inhibitors
Imidazoles
Heterocyclic Compounds
Phenyl-Triazole
Isoquinolines
Proton Pump Inhibitors
Chemical Precursors
23 patents (USPTO):Explore Patents
1. 9540332 - Benzimidazole derivatives as selective blockers of persistent sodium current (2017-01-10),
2. 8859780 - Benzimidazole derivatives as selective blockers of persistent sodium current (2014-10-14),
3. 7919630 - [object Object] (2011-04-05),
4. 7880017 - Process for the synthesis of imidazoles (2011-02-01),
5. 7598394 - Process for the synthesis of imidazoles (2009-10-06),
6. 7579481 - Method of making imidazole-2-ones and 2-thiones (2009-08-25),
7. 7294716 - Process for preparing isomerically pure prodrugs of proton pump inhibitors (2007-11-13),
8. 7183305 - Process for the synthesis of imidazoles (2007-02-27),
9. 7115748 - Method of making imidazole-2-thiones (2006-10-03),
10. 6372770 - Benzoxazoles (2002-04-16),
11. 6248769 - Phenyl-triazole compounds for PDE-IV inhibition (2001-06-19),
12. 6153630 - Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods (2000-11-28),
13. 6103749 - Aryl imidazole compounds having phosphodiesterase IV inhibitory activity (2000-08-15),
14. 5922751 - Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods (1999-07-13),
15. 5889014 - Heterocyclic compounds for inhibiting phosphodiesterase IV (1999-03-30),

Title: Innovations of Lloyd Jay Dolby: A Pioneer in Benzimidazole Derivatives

Introduction: Lloyd Jay Dolby, based in Eugene, Oregon, is a distinguished inventor with an impressive portfolio of 23 patents. His innovative work primarily focuses on the development of pharmaceutical compounds designed to improve treatment for various medical conditions.

Latest Patents: Among his latest patents, Lloyd has significantly contributed to the field with his invention of benzimidazole derivatives as selective blockers of persistent sodium current. These compounds are represented by a specific formula and include pharmaceutically acceptable salts. They play a critical role in treating a range of diseases and conditions, including ocular disorders, multiple sclerosis, seizure disorders, and chronic pain.

Career Highlights: Throughout his career, Lloyd has contributed his expertise to notable companies such as Allergan, Inc. and Euro-Celtique S.A. His work in these organizations has greatly influenced advances in pharmaceutical science.

Collaborations: Lloyd has had the privilege of working alongside other talented professionals, including Michael E. Garst and Shervin Esfandiari. These collaborations have fostered an environment of innovation, leading to remarkable advancements in the medical field.

Conclusion: Lloyd Jay Dolby's contributions through his patents and collaborations mark him as a key figure in the development of pharmaceutical innovations. His commitment to addressing significant medical challenges through his inventions demonstrates the vital role inventors play in transforming healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…